The Stop Loss Market: Carrier Concentration, Loss Ratios, and Capacity Cycles
Series 02: The Risk Layer | Article 02.06 | Sharp Analysis
Market Size and Carrier Concentration#
The U.S. employer stop loss market generated approximately $35.5 billion in annual premium in 2023, according to Oliver Wyman and Guy Carpenter, covering 61 million people through self-funded plans. Premium volume grew at a compound rate of 11.9% from 2018 to 2023. Approximately 10% of annual growth reflected cost trends and business mix changes. The remainder came from increased enrollment as employers migrated from fully insured to self-funded arrangements. Enrollment in the fully insured medical market declined 14.2% over the same period, according to Oliver Wyman.
The market is served by two categories of carriers with fundamentally different business models. Independent stop loss carriers sell stop loss as a standalone product into the TPA distribution channel. The employer selects a TPA for plan administration and a separate stop loss carrier for risk transfer. Sun Life ranks as the largest independent stop loss carrier by NAIC premium data. Voya Financial covers approximately 2.2 million employees through its stop loss book. Symetra, HM Insurance Group (a Highmark subsidiary), Berkley Accident and Health, Tokio Marine HCC, and QBE North America represent additional major independent market participants. Nationwide’s July 2025 completion of its $1.25 billion acquisition of Allstate’s employer stop loss segment positions Nationwide as a significant new entrant, serving over 13,000 small businesses. Prudential Financial launched a new stop loss product in September 2024, further expanding the independent carrier field.
Carrier-affiliated stop loss is bundled within proprietary level funded products from UnitedHealthcare, Aetna, Cigna, and other large health insurers. These bundled products integrate stop loss underwriting with the carrier’s administrative platform, network, and pharmacy benefit. The employer purchases a single product rather than assembling components. The carrier-affiliated model controls a substantial portion of the small group level funded market because it offers simplicity: one carrier, one contract, one point of accountability. The tradeoff is that the employer surrenders the ability to select best-in-class components independently.
The market concentration has practical consequences for employers. When the major carriers increase premiums, the market follows. New entrant carriers and MGAs provide competitive pressure at the margins but lack the book of business to shift overall market pricing. A major carrier exiting the stop loss market (or dramatically reducing appetite for a segment) would materially affect availability and pricing for the employers in that segment. The risk is asymmetric: carrier entry creates modest competitive benefit, while carrier exit creates acute supply disruption.
Loss Ratios and Underwriting Performance#
Whether stop loss carriers are making or losing money on their underwriting determines what employers pay at renewal, regardless of any individual group’s claims experience.
The loss ratio measures claims paid as a percentage of premium earned. A loss ratio of 80% means the carrier paid $0.80 in claims for every $1.00 of premium. After expenses (underwriting, administration, reinsurance costs), a loss ratio below 75% to 80% generally indicates profitable underwriting. Above 85%, the carrier is likely losing money. The combined ratio, which adds the expense ratio to the loss ratio, provides the complete profitability picture.
Stop loss loss ratios deteriorated from 79.5% in 2018 to 80.3% in 2023, according to Oliver Wyman’s analysis of NAIC data. The earlier Guy Carpenter report documented a steeper deterioration from 78.5% in 2017 to 84.1% in 2022, a period encompassing the pandemic’s impact on claims patterns. Several forces drove the deterioration. Medical cost trend accelerated beyond carrier pricing assumptions. The frequency of claims exceeding $1 million increased more than 34% over a three-year period. Claims exceeding $2 million increased 62%. Claims exceeding $5 million increased 275%. Cancer treatments, premature births, and specialty pharmacy costs were the primary drivers of large claim growth.
Voya’s third-quarter 2024 results illustrated the pressure at the carrier level. Its stop loss business collected $453 million in premiums and paid $424 million in benefits, producing a benefit-to-premium ratio of 93.4%, up from 83.3% in the same quarter of the prior year. Operating gain fell from $51 million to $29 million. Sales of new stop loss coverage fell from $67 million to $35 million as the carrier tightened underwriting. Sun Life reported stop loss premium and fee revenue of $693 million in the same quarter, up from $646 million the prior year, though its sales were essentially flat at $68 million.
The 2025 Aegis Risk survey documented the downstream consequences. Among 1,268 plan sponsors covering over 1.2 million employees, 49% now report claims in excess of $1 million, up from 23% in 2024. Claims in excess of $2 million are reported by 16% of respondents. The survey measured single-year stop loss premium increases of 8.8% to 10.5% from 2024 to 2025, with increases escalating as attachment points rise (reflecting leveraged trend). Major carriers including Cigna, Voya, and Sun Life experienced difficult claims in Q4 2024, driven by advanced cancer treatments, premature births, and health system revenue strategies. These carrier-level losses will feed directly into 2026 renewal pricing.
The employer-level implication is clear. When carrier loss ratios are elevated, employers face premium increases even when their own group’s claims experience is favorable. The carrier is repricing its entire book to restore target margins. A 20-person group with clean claims in a year when the carrier’s aggregate book performed poorly will still receive a renewal increase that reflects the carrier’s portfolio-level repricing. The employer did nothing wrong. The carrier is not being punitive. The market is adjusting to loss experience that the employer cannot see and cannot control.
Capacity Cycles#
The stop loss market follows a cyclical pattern of expansion and contraction that small group employers experience as unpredictable renewal volatility but that is, in fact, a recurring market dynamic.
During expansion (a soft market), carriers compete for business. Premium growth is a strategic priority. Pricing is competitive. Attachment points are flexible. Underwriting standards are more permissive. New carriers and MGAs enter the market, attracted by the growth opportunity and perceived profitability. Carriers expand their appetite for small groups, groups with moderate risk, and groups with limited claims history.
During contraction (a hard market), loss experience deteriorates. Carriers increase prices, restrict appetite, tighten underwriting, and in some cases exit the market. Reinsurance costs increase, compounding the correction. The cycle has historically run several years from trough to peak, though the duration varies with the severity of the triggering loss events and the pace of capital replenishment.
Small groups are disproportionately affected by hard markets. When carriers tighten appetite, they restrict small group business first. The risk-reward ratio for small group stop loss is the least favorable in the carrier’s portfolio: small groups generate less premium per account, require proportionally higher administrative costs, produce more volatile claims experience, and create greater adverse selection exposure. When a carrier decides to reduce its book to improve profitability, the 10-person groups go before the 200-person groups.
The current market position reflects the tail end of a corrective pricing phase that began in 2022 when carrier loss ratios deteriorated significantly. Premium increases of 8% to 13% annually, more aggressive laser application, and higher minimum attachment points for small groups have been the primary market responses. Whether the correction has restored sufficient profitability to begin softening the market, or whether sustained medical cost acceleration is producing a structural (rather than cyclical) repricing, is the central question for the market entering 2026.
Cell and gene therapies represent an emerging pressure on the cycle. QBE North America reported only three gene therapy claims between 2022 and 2024 across nearly 2 million covered lives. The frequency remains low. But individual gene therapy claims can exceed $3 million, and the pipeline of FDA-approved cell and gene therapies has been expanding rapidly, with seven new therapies approved in 2024 alone and over 20 conditions now covered across more than eight disease categories. Carriers and reinsurers are pricing for a future in which these therapies become more common, and that forward pricing contributes to current premium increases even though the claim frequency has not yet materialized.
Market Transparency and Information Asymmetry#
The stop loss market operates with significant information asymmetry between carriers and purchasers. The asymmetry is structural, not the product of deliberate concealment, and it favors the carrier in every transaction.
The carrier knows its own book performance, its loss ratios by segment, its reinsurance costs, and its market positioning strategy. It knows which group sizes and industries are producing favorable versus unfavorable experience across its portfolio. It knows its target margins and its appetite constraints. The employer and broker know none of this. They see individual carrier quotes and renewal offers. They know the group’s own claims experience. They may have general market intelligence from industry surveys like the Aegis report, published with some lag.
An experienced stop loss broker who places coverage with multiple carriers across hundreds of groups has more market intelligence than a generalist broker placing a handful of groups annually. The specialized broker recognizes when a carrier’s renewal quote reflects group-specific repricing versus market-wide repricing versus carrier appetite restriction. They know which carriers are expanding appetite for a particular group profile and which are contracting. This market intelligence is a structural advantage of experienced stop loss brokers and one of the primary reasons that broker specialization matters more in stop loss than in most other lines of employee benefits.
A renewal increase may reflect the group’s own claims experience, the carrier’s book-wide repricing, reinsurance cost increases, or any combination of the three. The employer cannot disaggregate the causes without carrier-level data the carrier does not share. A broker who can contextualize the renewal within broader market conditions provides the employer with the information needed to make an informed decision: accept the renewal, negotiate, seek alternative carriers, or evaluate returning to fully insured.
The opacity is compounded upstream. Reinsurance treaty terms and pricing are not disclosed to the employer-facing market. Carrier-level loss ratios for specific segments (small group, large group, by industry) are not published. Why a specific carrier declined a group or non-renewed is not explained in underwriting detail. The employer making what may be the single largest annual financial decision in their benefits program, the stop loss purchase, does so with less market transparency than they would have buying office equipment.
The information asymmetry is not a regulatory gap that legislation can close. It is an inherent feature of a layered risk transfer market in which each participant knows its own position and its counterparties but not the full chain. The employer’s defense is broker expertise, carrier diversification (soliciting multiple quotes to triangulate market pricing), and an understanding that the forces driving their renewal are not personal but structural. The stop loss carrier is not the employer’s adversary. It is a participant in a market governed by forces that neither the carrier nor the employer fully controls.
How this article connects to others in Blue Gray Matters.
Sources cited in this article.
- Aegis Risk LLC. *2025 Medical Stop-Loss Premium Survey*. International Foundation of Employee Benefit Plans, 2025.
- Guy Carpenter and Oliver Wyman. *Stop Loss Market Update, Fall 2023*. Marsh McLennan, 2023.
- Nationwide. "Nationwide Completes Acquisition of Allstate Employer Stop Loss Business for $1.25 Billion." Press release, 1 July 2025.
- Oliver Wyman and Guy Carpenter. "Top Trends Shaping the Healthcare Stop Loss Market." Oliver Wyman, Sept. 2024.
- Prudential Financial. "Prudential Financial Introduces Stop Loss Insurance." Press release, 19 Sept. 2024.
- QBE North America. *2025 Accident and Health Market Report*. QBE, 2025.
- Voya Financial. *Third Quarter 2024 Earnings Results*. Voya Financial, 2024.
- "Voya Is Doubling Stop-Loss Price Increases for 2025." *BenefitsPRO*, 5 Nov. 2024.